Literature DB >> 14960635

Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction.

Mario Quarantelli1, Karim Berkouk, Anna Prinster, Brigitte Landeau, Claus Svarer, Laszlo Balkay, Bruno Alfano, Arturo Brunetti, Jean-Claude Baron, Marco Salvatore.   

Abstract

UNLABELLED: We present software for integrated analysis of brain PET studies and coregistered segmented MRI that couples a module for automated placement of regions of interest (ROI) with 4 alternative methods for partial-volume-effect correction (PVEc). The accuracy and precision of these methods have been measured using 4 simulated (18)F-FDG PET studies with increasing degrees of atrophy.
METHODS: The software allows the application of a set of labels, defined a priori in the Talairach space, to segmented and coregistered MRI. Resulting ROIs are then transferred onto the PET study, and corresponding values are corrected according to the 4 PVEc techniques under investigation, providing corresponding corrected values. To evaluate the PVEc techniques, the software was applied to 4 simulated (18)F-FDG PET studies, introducing increasingly larger experimental errors, including errors in coregistration (0- to 6-pixel misregistration), segmentation (-13.7% to 14.1% gray matter [GM] volume change) and resolution estimate errors (-16.9% to 26.8% full-width-at-half-maximum mismatch).
RESULTS: Even in the absence of segmentation and coregistration errors, uncorrected PET values showed -37.6% GM underestimation and 91.7% WM overestimation. Voxel-based correction only for the loss of GM activity as a result of spill-out onto extraparenchymal tissues left a residual underestimation of GM values (-21.2%). Application of the method that took into account both spill-in and spill-out effects between any possible pair of ROIs (R-PVEc) and of the voxel-based method that corrects also for the WM activity derived from R-PVEC (mMG-PVEc) provided an accuracy above 96%. The coefficient of variation of the GM ROIs, a measure of the imprecision of the GM concentration estimates, was 8.5% for uncorrected PET data and decreased with PVEc, reaching 6.0% for mMG-PVEc. Coregistration errors appeared to be the major determinant of the imprecision.
CONCLUSION: Coupling of automated ROI placement and PVEc provides a tool for integrated analysis of brain PET/MRI data, which allows a recovery of true GM ROI values, with a high degree of accuracy when R-PVEc or mMG-PVEc is used. Among the 4 tested PVEc methods, R-PVEc showed the greatest accuracy and is suitable when corrected images are not specifically needed. Otherwise, if corrected images are desired, the mMG-PVEc method appears the most adequate, showing a similar accuracy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14960635

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  82 in total

1.  Age-related metabolic profiles in cognitively healthy elders: results from a voxel-based [18F]fluorodeoxyglucose-positron-emission tomography study with partial volume effects correction.

Authors:  P K Curiati; J H Tamashiro-Duran; F L S Duran; C A Buchpiguel; P Squarzoni; D C Romano; H Vallada; P R Menezes; M Scazufca; G F Busatto; T C T F Alves
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-27       Impact factor: 3.825

2.  Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography.

Authors:  J Hirvonen; P Zanotti-Fregonara; J C Umhau; D T George; D Rallis-Frutos; C H Lyoo; C-T Li; C S Hines; H Sun; G E Terry; C Morse; S S Zoghbi; V W Pike; R B Innis; M Heilig
Journal:  Mol Psychiatry       Date:  2012-07-10       Impact factor: 15.992

3.  Dopamine transporter availability in clinically normal aging is associated with individual differences in white matter integrity.

Authors:  Anna Rieckmann; Trey Hedden; Alayna P Younger; Reisa A Sperling; Keith A Johnson; Randy L Buckner
Journal:  Hum Brain Mapp       Date:  2015-11-06       Impact factor: 5.038

4.  Direct voxel-based comparisons between grey matter shrinkage and glucose hypometabolism in chronic alcoholism.

Authors:  Ludivine Ritz; Shailendra Segobin; Coralie Lannuzel; Céline Boudehent; François Vabret; Francis Eustache; Hélène Beaunieux; Anne L Pitel
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-14       Impact factor: 6.200

5.  Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer?

Authors:  Sandip Basu; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10       Impact factor: 9.236

6.  Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT.

Authors:  Andrea Varrone; Nils Sjöholm; Lars Eriksson; Balazs Gulyás; Christer Halldin; Lars Farde
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-13       Impact factor: 9.236

7.  Image coregistration: quantitative processing framework for the assessment of brain lesions.

Authors:  Hannu Huhdanpaa; Darryl H Hwang; Gregory G Gasparian; Michael T Booker; Yong Cen; Alexander Lerner; Orest B Boyko; John L Go; Paul E Kim; Anandh Rajamohan; Meng Law; Mark S Shiroishi
Journal:  J Digit Imaging       Date:  2014-06       Impact factor: 4.056

8.  Different partial volume correction methods lead to different conclusions: An (18)F-FDG-PET study of aging.

Authors:  Douglas N Greve; David H Salat; Spencer L Bowen; David Izquierdo-Garcia; Aaron P Schultz; Ciprian Catana; J Alex Becker; Claus Svarer; Gitte M Knudsen; Reisa A Sperling; Keith A Johnson
Journal:  Neuroimage       Date:  2016-02-23       Impact factor: 6.556

9.  Practical method for radioactivity distribution analysis in small-animal PET cancer studies.

Authors:  Nikolai V Slavine; Peter P Antich
Journal:  Appl Radiat Isot       Date:  2008-06-14       Impact factor: 1.513

10.  Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study.

Authors:  Lisbeth Marner; Gitte M Knudsen; Steven Haugbøl; Søren Holm; William Baaré; Steen G Hasselbalch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-01       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.